3. About the Endocrinology Clinical Committee

The Endocrinology Clinical Committee (the Committee) is part of the second tranche of clinical committees. It was established in April 2016 to make recommendations to the Taskforce on MBS items within its remit, based on rapid evidence review and clinical expertise.

The Committee consists of 13 members and three additional working group members, whose names, positions/organisations and declared conflicts of interest are listed in Sections 3.1 and 3.2. All members of the Taskforce, clinical committees and working groups were asked to declare any conflicts of interest at the start of their involvement and are reminded to update their declarations periodically.

3.1 Committee members

Table 1: Committee members

Name Position/Organisation Declared conflict of interest

Professor Jonathan Serpell (Chair)

Head, Breast, Endocrine & General Surgery, The Alfred;
Professor & Director, General Surgery, The Alfred, Monash University;
Past Chairman, Section of Endocrine Surgeons, Royal Australasian College of Surgeons;
Past President, Australian and New Zealand Endocrine Surgeons

Uses the MBS items under review.

Professor Timothy Davis

Professor of Medicine, University of Western Australia;
Consultant Physician and Endocrinologist, Fremantle Hospital

Uses the MBS items under review.

Professor Duncan Topliss

Director, Department of Endocrinology & Diabetes, Alfred Hospital, Melbourne; Professor of Medicine in the Department of Medicine, Monash University

Uses the MBS items under review; has given talks and previously provided advisory work for Genzyme and other pharmaceutical companies, and has contributed to their research; and has received money from thyroid cancer trials from Eisai.

Associate Professor Roderick Clifton-Bligh

Head of the Department of Endocrinology at Royal North Shore Hospital; Conjoint Associate Professor in Medicine at the University of Sydney

Uses the MBS items under review; has given talks for numerous pharmaceutical companies and contributed to their research; and has received money from thyroid cancer trials.

Professor Stan Sidhu

Professor of Surgery & Head of Endocrine Surgical Unit, University of Sydney & Royal North Shore Hospital;
Professor, Surgery, Northern Clinical School, Kolling Institute of Medical Research, University of Sydney;
President, Australian and New Zealand Endocrine Surgeons

Uses the MBS item numbers under review.

Dr Christopher Pyke

Surgeon, Mater Private Hospital Brisbane & Mater Private Breast Cancer Centre

Uses the MBS items under review.

Mr Peter Malycha

Director, Endocrine Surgery, Royal Adelaide Hospital;
Clinical Lecturer, Department of Surgery, University of Adelaide;
Consultant Surgeon, Adelaide Women’s and Children’s Hospital;
Clinical Director, Translational Research Institute, Princess Alexandra Hospital, Centres for Health Research

Uses the MBS items under review.

Ms Helen Maxwell-Wright

Director, Maxwell-Wright Associates;
Panel of Chairs, Monitoring Committee, Medicines Australia
Quality & Safety Committee, Australian and New Zealand College of Anaesthetists;
Former Managing Director, International Diabetes Institute;
Chair, Community Advisory Group, College of Intensive Care Medicine;
Chair of State Leadership Group Victoria Juvenile Diabetes Research Foundation;
MBS Review Representative Consumer

Consults for Grey Innovation/Firefly about a device under development for diabetes management.

Dr Suzanne Silberberg

Consultant Endocrinologist, private practice

Uses the MBS items under review.

Ms Janne Graham

Nominee of Consumers Health Forum;
Has formerly represented consumer interests in such roles as: Member of NHMRC, Vice-Chair of Australian Pharmaceutical Advisory Council and Member of TGA Advisory Committee on Prescription Medicines;
Consumer representative; healthcare advocate

Has been a patient receiving endocrine specialist services.

Dr Allan Wycherley

Head, Nuclear Medicine Unit, Division of Medical Imaging, Flinders Medical Centre

Uses the MBS items under review.

Professor Bruce Robinson

Chair of MBS Review Taskforce and Ex-Officio for the Committee;
Chair of Australia’s National Health, and Medical Research Council;
Head of the Cancer Genetics Unit at the Kolling Institute of Medical Research, Royal North Shore Hospital;
Endocrinologist, Royal North Shore Hospital

Used the item numbers and has conducted talks for Genzyme; previously on the Board for AstraZeneca and Bayer; currently on the Board for Mayne Pharma.

Dr Jo-Anne Manski-Nankervis

General Practitioner, Lecturer in Primary Care and Diabetes Research Fellow, Representative for the Department of General Practice, University of Melbourne; Primary Care Diabetes Society of Australia; Eastbrooke Medical Centres

Uses the items under review as a requesting GP.


3.2 Working group members

Table 2: Thyroid Stimulating Hormone (TSH), Thyroid Function Test (TFT) and Thyroid Antibodies Working Group members

Name Position/Organisation Declared conflict of interest

Associate Professor Roderick Clifton-Bligh (Chair)

As above

As above

Professor Duncan Topliss

As above

As above

Dr Suzanne Silberberg

As above

As above

Dr Jo-Anne Manski-Nankervis

As above

As above

Professor Hans Schneider

Director of Pathology, Alfred Pathology Service (Melbourne);
Adjunct Clinical Professor, Central Clinical School, Monash University;
President, Public Pathology Australia

Is the main biller of the tests at the Alfred, although these do not get billed under the MBS.

Dr Simon Morgan

General Practitioner

Requests the MBS items under review.


Table 3: Thyroid Surgical Volumes and Outcomes Working Group members

Name Position/Organisation Declared conflict of interest

Professor Jonathan Serpell (Chair)

As above

As above

Professor Stan Sidhu

As above

As above

Ms Janne Graham

As above

As above

Dr Christopher Pyke

As above

As above




|

_________________________________________